IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 85 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $213,000 | +71.8% | 58,061 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $124,000 | +19.2% | 58,061 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $104,000 | +35.1% | 58,061 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $77,000 | -27.4% | 58,061 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $106,000 | -36.9% | 58,061 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $168,000 | +8.4% | 58,061 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $155,000 | +4.7% | 58,061 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $148,000 | -8.1% | 58,061 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $161,000 | -68.9% | 58,061 | 0.0% | 0.00% | -75.0% |
| Q3 2018 | $517,000 | – | 58,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |